Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-03

FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

The FDA approved a supplemental application for Claritin-D 24 Hour, a loratadine/pseudoephedrine sulfate combination from Bayer HealthCare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLARITIN-D 24 HOUR (loratadine and pseudoephedrine sulfate)

Snippet

SUPPL AP for CLARITIN-D 24 HOUR (LORATADINE AND PSEUDOEPHEDRINE SULFATE)